Market Considerations for Nanomedicines and Theranostic Nanomedicines

Alexander, Archie A. and Jotterand, Fabrice. (2014) Market Considerations for Nanomedicines and Theranostic Nanomedicines. In: Cancer Theranostics. Amsterdam, pp. 471-491.

Full text not available from this repository.

Official URL: http://edoc.unibas.ch/39337/

Downloads: Statistics Overview


Theranostics combines diagnostic tests with therapeutic interventions to create individualized therapies for patients. Nanotechnology is an enabling technology that helps produce single particle combinations and delivery systems for theranostic applications. Nanomaterials have novel properties derived from the manipulation of matter at the molecular level. Their application in medicine (nanomedicine) promises to revolutionize health care through theranostic nanomedicines (nanotheranostics). Nanotheranostics may enable physicians to diagnose diseases, deploy treatments, and monitor efficacies using a single platform. Although the future for nano appears bright, getting nanotheranostics from the benchtop to bedside applications may prove challenging. Researchers, entrepreneurs, investors, and consumers face a variety of technical, market, regulatory, legal, ethical, and policy challenges. This chapter provides an overview of commercialization of nanotechnology, nanomedicine, and theranostic nanomedicine (nanotheranostics) as a foundation for understanding the challenges of bring theranostics to market.
Faculties and Departments:08 Cross-disciplinary Subjects > Ethik > Institut für Bio- und Medizinethik > Bio- und Medizinethik (Elger)
03 Faculty of Medicine > Departement Public Health > Ethik in der Medizin > Bio- und Medizinethik (Elger)
UniBasel Contributors:Jotterand, Fabrice
Item Type:Book Section, refereed
Book Section Subtype:Further Contribution in a Book
Note:Publication type according to Uni Basel Research Database: Book item -- Edition: First Edition
Related URLs:
Identification Number:
Last Modified:19 Jul 2016 07:33
Deposited On:19 Jul 2016 07:33

Repository Staff Only: item control page